More about Narayana Hrudayalaya Limited
Fundamentals for Narayana Hrudayalaya Limited
Regulatory Filings for Narayana Hrudayalaya Limited
Apollo FY26: When Healthcare Becomes a Flywheel
NITI Blueprint Could Turn Brain Drain Into $135Bn Engine
RAINMUMBAI Turns Rain Into a Financial Asset
India’s IT Sector Faces a Historic Breaking Point
Fundamentals for Narayana Hrudayalaya Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Narayana Hrudayalaya Limited engages in the medical and healthcare services in India and internationally. It operates through two segments, Medical and Healthcare Related Services; and Others. The company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centres, nursing homes and other related activities. It offers cardiology, cardiac surgery, nephrology, urology, neurology, neuro-surgery, endocrinology, orthopedics, internal medicines, obstetrics, gynecology, pediatrics, neonatology, gastroenterology, and oncology services. The company engages in health insurance business. The company was incorporated in 2000 and is headquartered in Bengaluru, India.
Revenue projections:
Investors may react cautiously to news that NH's revenues are forecasted to be lower than last year's. Such declines are likely to have a negative effect on the company's bottom line, which can lead to concerns about profitability and hinder investor confidence in the company's future performance.
Financial Ratios:
| currentRatio | 2.152000 |
|---|---|
| forwardPE | 27.779566 |
| debtToEquity | 129.033000 |
| earningsGrowth | 0.136000 |
| revenueGrowth | 0.826000 |
| grossMargins | 0.447510 |
| operatingMargins | 0.169420 |
| trailingEps | 39.910000 |
| forwardEps | 69.122750 |
NH's current ratio is 2.152, signaling that the company has sufficient cash reserves and current assets to cover its short-term debt obligations. This suggests financial stability, as NH should not face any issues meeting its short-term liabilities with available resources.
Narayana Hrudayalaya Limited's Forward PE is positioned well, reflecting a favorable balance between stock price and earnings. The stock isn't overpriced, offering room for growth and making it a potentially rewarding investment as its value has room to rise further.
NH's high debt-to-equity ratio points to a heavily leveraged company, with more debt than equity in its capital structure. While this can boost growth, it increases financial vulnerability in times of economic difficulty.
Positive earnings and revenue growth for NH suggest that the company is expected to grow its business. This trend reflects strong financial performance, with continued profitability and sales increases indicating a bright outlook for future expansion.
Narayana Hrudayalaya Limited's forward EPS being higher than its trailing EPS signals anticipated growth in profitability for the current financial year. This suggests that Narayana Hrudayalaya Limited is on track to improve its earnings, outpacing the previous year's performance and reflecting positive market expectations.
Price projections:
NH's price has continuously remained near the lower end of analysts' projections, indicating that it may be facing challenges in meeting market expectations. This trend raises concerns about the company's future growth trajectory.
Insider Transactions:
There were 1 NH sales transactions, at market price of 1957.300048828125.Throughout the period under consideration, there were no sell transactions.NH's current price levels are experiencing more buying activity than selling, which may point to a favorable outlook. This trend suggests investor confidence in the stock's future, potentially indicating expectations of continued growth.
Recommendation changes over time:
Analysts are favoring Narayana Hrudayalaya Limited with a buy bias, highlighting the stock's potential as a solid investment. This recommendation might drive more investors to consider Narayana Hrudayalaya Limited as a secure and profitable option for their money, contributing to a broader positive sentiment in the market.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
How Independent Directors Failed Rs 2,500 Crore in Value
India’s Stock Market May Be Sitting on a Trap